DiosCURE is advancing next-generation best-in-class immunotherapeutics to prevent and treat SARS-CoV-2 in order to combat the ongoing coronavirus pandemic. Due to their small size, our drug candidates can attach to unique surface structures of the SARS-CoV-2 spike protein.
This passive immunization approach will block the virus’ penetration into target cells which inhibits viral spreading and thereby allows the prevention a...
DiosCURE is advancing next-generation best-in-class immunotherapeutics to prevent and treat SARS-CoV-2 in order to combat the ongoing coronavirus pandemic. Due to their small size, our drug candidates can attach to unique surface structures of the SARS-CoV-2 spike protein.
This passive immunization approach will block the virus’ penetration into target cells which inhibits viral spreading and thereby allows the prevention and treatment of SARS-CoV-2 infections.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.